Oppenheimer Asset Management Inc. Acquires New Stake in Albemarle Corporation $ALB

Posted by Brenda Bartman on Aug 18th, 2026

Oppenheimer Asset Management Inc. bought a new position in Albemarle Corporation (NYSE:ALB – Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 4,120 shares of the specialty chemicals company’s stock, valued at approximately $556,000.

Other institutional investors have also added to or reduced their stakes in the company. AQR Capital Management LLC increased its position in shares of Albemarle by 25.5% in the first quarter. AQR Capital Management LLC now owns 3,223 shares of the specialty chemicals company’s stock worth $229,000 after purchasing an additional 654 shares during the last quarter. Integrated Wealth Concepts LLC lifted its position in Albemarle by 26.2% during the first quarter. Integrated Wealth Concepts LLC now owns 4,798 shares of the specialty chemicals company’s stock valued at $346,000 after purchasing an additional 996 shares during the last quarter. United Services Automobile Association purchased a new position in Albemarle in the 1st quarter worth approximately $208,000. Empowered Funds LLC purchased a new position in Albemarle in the 1st quarter worth approximately $411,000. Finally, EverSource Wealth Advisors LLC increased its holdings in shares of Albemarle by 536.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 573 shares of the specialty chemicals company’s stock worth $36,000 after buying an additional 483 shares during the last quarter. 92.87% of the stock is currently owned by institutional investors.

Albemarle Trading Down 1.4%

Shares of ALB opened at $134.22 on Tuesday. Albemarle Corporation has a fifty-two week low of $71.25 and a fifty-two week high of $221.00. The firm has a market cap of $15.84 billion, a price-to-earnings ratio of 497.13 and a beta of 1.33. The firm has a 50 day moving average price of $133.73 and a 200-day moving average price of $161.80. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.35 and a current ratio of 2.09.

Albemarle (NYSE:ALB – Get Free Report) last released its earnings results on Wednesday, August 5th. The specialty chemicals company reported $3.75 EPS for the quarter, beating the consensus estimate of $3.20 by $0.55. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.61 billion. Albemarle had a net margin of 3.09% and a return on equity of 10.96%. The firm’s quarterly revenue was up 31.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.11 EPS. As a group, equities research analysts forecast that Albemarle Corporation will post 11.91 earnings per share for the current year.

Albemarle Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Friday, September 11th will be paid a dividend of $0.41 per share. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.2%. This is an increase from Albemarle’s previous quarterly dividend of $0.41. The ex-dividend date of this dividend is Friday, September 11th. Albemarle’s payout ratio is 600.00%.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on ALB. Berenberg Bank lifted their price objective on shares of Albemarle from $153.00 to $192.00 and gave the stock a “hold” rating in a report on Tuesday, June 2nd. Wells Fargo & Company raised their price target on Albemarle from $165.00 to $200.00 and gave the company an “equal weight” rating in a research report on Friday, May 8th. Robert W. Baird dropped their price target on Albemarle from $236.00 to $224.00 and set a “neutral” rating for the company in a research note on Thursday, June 18th. Argus lifted their price target on Albemarle from $185.00 to $230.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Finally, Mizuho cut their price objective on Albemarle from $205.00 to $185.00 and set a “neutral” rating for the company in a report on Wednesday, July 1st. Fifteen equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $190.26.

View Our Latest Stock Analysis on ALB

Albemarle Company Profile

(Free Report)

Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.

Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.